TWSTTwist Bioscience Corp

Nasdaq twistbioscience.com


$ 31.50 $ 0.46 (1.48 %)    

Friday, 26-Apr-2024 15:59:53 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 31.54
$ 31.04
$ 31.51 x 200
$ 31.54 x 100
$ 30.82 - $ 31.69
$ 11.46 - $ 43.21
644,436
na
1.81B
$ 1.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-02-2024 12-31-2023 10-Q
2 11-21-2023 09-30-2023 10-K
3 08-07-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 02-07-2023 12-31-2022 10-Q
6 11-28-2022 09-30-2022 10-K
7 08-08-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 02-09-2022 12-31-2021 10-Q
10 11-23-2021 09-30-2021 10-K
11 08-09-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-09-2021 12-31-2020 10-Q
14 11-27-2020 09-30-2020 10-K
15 08-12-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 02-10-2020 12-31-2019 10-Q
18 12-13-2019 09-30-2019 10-K
19 08-09-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 02-11-2019 12-31-2018 10-Q
22 12-20-2018 09-30-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-twist-bioscience-lowers-price-target-to-40

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $4...

 cathie-woods-ark-invest-offloads-69m-worth-of-coinbase-robinhood-shares-each-amid-searing-bitcoin-rally--nvidia-stock-also-shed

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such a...

 twist-bioscience-and-element-biosciences-collaborate

Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow expected to be available soon

 twist-bioscience-launches-cfdna-library-preparation-kit-for-liquid-biopsy-applications

High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA ...

 scotiabank-maintains-sector-outperform-on-twist-bioscience-raises-price-target-to-43

Scotiabank analyst Sung Ji Nam maintains Twist Bioscience (NASDAQ:TWST) with a Sector Outperform and raises the price target...

 twist-bioscience-unveils-differentiated-ultra-high-throughput-library-preparation-solution-at-agbt

Early access of novel technology that enables preparation of thousands of samples at low cost through self-normalization, enhan...

 why-is-dna-synthesis-company-twist-bioscience-stock-trading-higher-today

Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%.

 twist-bioscience-q1-eps-075-beats-078-estimate-sales-7150m-beat-6758m-estimate

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0....

 earnings-scheduled-for-february-2-2024

Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on re...

 twist-bioscience-earnings-preview
Twist Bioscience Earnings Preview
02/01/2024 15:01:46

 barclays-maintains-overweight-on-twist-bioscience-raises-price-target-to-45

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $3...

 twist-bioscience-expands-express-genes-rapid-synthesis-service

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION